SLC47A2
Multidrug and toxin extrusion protein 2
Also known as: FLJ31196, MATE2, MATE2-K, S47A2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q86VL8
- Gene
- SLC47A2
- Ensembl
- ENSG00000180638
- Chromosome
- 17
- Canonical length
- 602 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a protein belonging to a family of transporters involved in excretion of toxic electrolytes, both endogenous and exogenous, through urine and bile. This transporter family shares homology with the bacterial MATE (multidrug and toxin extrusion) protein family responsible for drug resistance. This gene is one of two members of the MATE transporter family located near each other on chromosome 17. Alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
602 residues, UniProt reviewed canonical sequence.
>Q86VL8|SLC47A2
1 MDSLQDTVAL DHGGCCPALS RLVPRGFGTE MWTLFALSGP LFLFQVLTFM IYIVSTVFCG
61 HLGKVELASV TLAVAFVNVC GVSVGVGLSS ACDTLMSQSF GSPNKKHVGV ILQRGALVLL
121 LCCLPCWALF LNTQHILLLF RQDPDVSRLT QDYVMIFIPG LPVIFLYNLL AKYLQNQGWL
181 KGQEEESPFQ TPGLSILHPS HSHLSRASFH LFQKITWPQV LSGVVGNCVN GVANYALVSV
241 LNLGVRGSAY ANIISQFAQT VFLLLYIVLK KLHLETWAGW SSQCLQDWGP FFSLAVPSML
301 MICVEWWAYE IGSFLMGLLS VVDLSAQAVI YEVATVTYMI PLGLSIGVCV RVGMALGAAD
361 TVQAKRSAVS GVLSIVGISL VLGTLISILK NQLGHIFTND EDVIALVSQV LPVYSVFHVF
421 EAICCVYGGV LRGTGKQAFG AAVNAITYYI IGLPLGILLT FVVRMRIMGL WLGMLACVFL
481 ATAAFVAYTA RLDWKLAAEE AKKHSGRQQQ QRAESTATRP GPEKAVLSSV ATGSSPGITL
541 TTYSRSECHV DFFRTPEEAH ALSAPTSRLS VKQLVIRRGA ALGAASATLM VGLTVRILAT
601 RHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC47A2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 13
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 123 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 123 nTPM
- kidney: 61 nTPM
- fallopian tube: 9.4 nTPM
- hippocampal formation: 9.2 nTPM
- hypothalamus: 8.4 nTPM
- basal ganglia: 6.4 nTPM
Single-cell type
- ependymal cells: 489 nCPM
- proximal tubule cells: 299 nCPM
- choroid plexus epithelial cells: 158 nCPM
- epididymal efferent duct ciliated cells: 142 nCPM
- epicardial cells: 114 nCPM
- fallopian tube ciliated cells: 61 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 79 nTPM
- midbrain: 46 nTPM
- medulla oblongata: 26 nTPM
- spinal cord: 18 nTPM
- hypothalamus: 15 nTPM
- pons: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.35
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- organic cation transport
- transmembrane transport
- xenobiotic detoxification by transmembrane export across the plasma membrane
Molecular functions
- antiporter activity
- organic cation transmembrane transporter activity
- polyspecific organic cation:proton antiporter activity
- transmembrane transporter activity
- xenobiotic transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC47A2 as an antibody target. Whether an autoantibody or antibody against SLC47A2 could matter depends on whether native SLC47A2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC47A2 is annotated at the cell surface, where native SLC47A2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC47A2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...